Integrating cardiomyocytes from human pluripotent stem cells in safety pharmacology: has the time come?
Luca SalaMilena BellinChristine L MummeryPublished in: British journal of pharmacology (2016)
This article is part of a themed section on New Insights into Cardiotoxicity Caused by Chemotherapeutic Agents. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v174.21/issuetoc.